STERIALS

A biopharmaceutical company focused on discovering, developing and delivering next generation immunotherapies with a focus on cancer treatment. The company has a pipeline of cancer treatments utilizing a proprietary platform that enables the modular design of product candidates, and is developing a treatment for unresectable locally advanced and metastatic squamous cell carcinoma of the head and neck. Based in Delaware.